drugset / Trial / NCT04997304
Teva Asthma Predictive Analytics Study
Phase 4
Completed
100 enrolled
University of Michigan
Teva Branded Pharmaceutical Products R&D, Inc. · collab
NaSingle-groupOpen-labelHealth-services research
Summary
This trial is being completed to determine baseline inhalation parameters and patterns of use in patients receiving treatment with TEVA digital inhalers, to develop predictive models for asthma exacerbations and response to biologics using data collected from these devices. Enrolled participants will complete questionnaires along with other study specific procedures. Additionally, in-person and phone visits will be performed.
Timeline
- Start
- 2021-07-09
- Primary completion
- 2023-12-14
- Completion
- 2023-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | AirDuo® Digihaler™ | Unknown | — | Inhaled |
| Background | ProAir® Digihaler™ | Unknown | 90 ug | Inhaled |